Current Research

CANINE EPILEPSY RESEARCH

Development of a Canine Epilepsy Program in Canada

The neurology service at the Ontario Veterinary College, University of Guelph and Dr. Minassian’s genetics research team at The Hospital for Sick Children (Sick Kids), University of Toronto would like to invite formally the Nova Scotia Duck Tolling Retriever (NSDTR) Club of Canada to participate in a research collaboration for the development of a Canine Epilepsy Program in Canada.

Canine epilepsy represents the most common neurological disease in dogs. It is estimated that 4% of all dogs are affected. In some breeds, the incidence is higher with frequencies in some families of dogs as high as 14%.

Recently, the Canadian Foundation for Innovation (CFI) awarded the neurology service at the Ontario Veterinary College, University of Guelph a research grant for the “Development of a comparative epilepsy program” where innovative research and collaboration among veterinary and human institutions will focus on similarities of the disease between the two species and targeting important aspects of the disorder including pathophysiology, diagnosis and treatment.

The Canine Epilepsy Program will consist of two closely connected research components: a clinical and genetic research component.

The clinical aspect of the research program will be performed by the neurology service at the Ontario Veterinary College, University of Guelph to investigate the phenomenology and clinical manifestations of canine seizures in epileptic dogs diagnosed with idiopathic epilepsy. A series of clinical and diagnostic tests will be conducted including a detailed history of the seizures, physical and neurological examinations, blood work, standard EEG recording, and brain magnetic resonance imaging (MRI).  The clinical component of this research program has the main objective to define common clinical and electroencephalographic seizure patterns in epileptic dogs belonging to a particular breed.

The genetic aspect of the research program will focus on the identification of genetic mutations in epileptic dogs. Based on the similarities and comparative aspects between human and canine epilepsy, a genetic research team lead by Dr. Berge Minassian at the Hospital for Sick Kids Children Toronto has been embarking on the discovery of genes causing canine epilepsy and other diseases. The common epilepsies, which afflict 1% of people worldwide, have proven extremely difficult to crack genetically and only some genes for rare large families are known.  Dogs will come to man's rescue in this regard.  Canine epilepsy is 5-10 times more common than human epilepsy and closely mimics human epilepsy syndromes. Dogs are emerging as a superior research companion for human geneticists because each pure breed represents a group of genetically similar animals. This increases the power of genetic studies. The dog genome has recently been sequenced, and genetic tools for gene mapping are now available.

Dr. Minassian's lab recently discovered the first canine epilepsy gene, Epm2b. Mutations in the same gene turned out to be a cause of Lafora progressive myoclonus epilepsy in humans.  These genetic studies are part of collaborative efforts with other international research groups including Dr. Hannes Lohi in Finland, Dr. Gary Johnson in Missouri, USA and Drs. Ned Patterson and Jim Mickleson in Minnesota, USA.

The genetic research team is collecting blood samples for DNA and accurate pedigree information for dog families that have a history of genetic epilepsy.  We wish to include your breed in our studies. We will need samples from both affected dogs and unaffected relatives to perform these genetic studies.

Identification of new epilepsy genes will increase our understanding of this common neurological disease. It will also allow us to devise a diagnostic test to eradicate the disease from affected breeds. The identified genes will be characterized and tested in human patient samples.  Ultimately, this research will improve both canine and human health.

We truly hope that you will find this clinical and genetic program an attractive and non-invasive research study to help all our companions animals suffering from idiopathic epilepsy.

 We will be happy to provide you with more information and description of this research project

 Looking forward to collaborating with you,

Sincerely,

Roberto Poma DMV, DVSc, ACVIM Neurology
Assistant Professor, Department of Clinical Studies
Ontario Veterinary College
University of Guelph
Guelph, ON, Canada, N1G 2W1

and

Berge A. Minassian, MD CM, FRCP(C) Neurology
Associate Professor, University of Toronto
Neurologist, Division of Neurology
Scientist, Program in Genetics and Genomic Biology
The Hospital for Sick Children
Toronto, ON, Canada, M5G 1X8

For more information on this project and how you can get involved, please contact Ruth Peacock at:  ruth.peacock@sympatico.ca
This is a NSDTR Club of Canada supported project so check for study updates at:
Where Your Research Dollars Are Being Spent

********************************************************************************************************************

American Based Epilepsy Research (working in conjunction with researchers from the Canadian Epilepsy Program)

Canine epilepsy is one of the most emotionally devastating problems facing dog owners and breeders today. Dr. Gary S. Johnson, a molecular geneticist from the College of Veterinary Medicine at the University of Missouri-Columbia is currently doing DNA research to try to locate the mutation(s) responsible for causing epilepsy in dogs. The genes controlling seizure problems in dogs are not well understood, but this project is attempting to find the marker(s) or mutation(s) responsible.  When these can be identified, a blood test will tell if an individual dog is a carrier, clear, or likely to become an affected (even before symptoms begin). Using this information, breeders can choose breeding partners who will not produce additional affected puppies. Researchers working on this project need information from affected dogs and their families.  Specifically, what is needed is a pedigree (4 or 5 generation) of the litter where an affected dog (or dogs) appeared, and blood samples from the affected(s), the littermates, parents, and when possible, the grandparents. More distant relatives such as half-siblings, aunts and uncles, or others are also potentially useful. Families are important so that the genotype of the affected dogs can be compared to that of close relatives who are not affected, and decipher how these genes are inherited from one generation to the next. An affected dog with little or no family available may also be useful to test information found in families, and should also send in a sample.  Participation in the project is completely confidential - the names of dogs and owners who participate in the research will not be revealed. When the research produces some results, individual owners will be able to request the results of testing on their own dogs. Results of research are published in such a way that the identity of individual dogs is completely anonymous, so participants do not have to worry that information, which could be traced to an individual dog or family, would be disclosed.  There is a packet of information sheets and forms for submitting samples.  You may make copies and distribute them to other interested breeders and owners who should also participate. The packet can be downloaded at the Canine Epilepsy Network website (currently under construction),

www.canine-epilepsy.net

or mailed via regular mail.  Several recently approved grants have allowed this research to be opened to affected dogs and their families in ALL breeds of dogs, at no cost to the owners or the breed parent clubs. As of early July, samples have been received from 15 different breeds. Within a year, researchers hope to have samples from at least 50 breeds.  It is hoped that information discovered in one breed may help locate mutations in another. Please spread the word of this research to anyone who has an affected dog or a relative of an affected dog, and to veterinarians and others who may come in contact with other dogs and owners who should be included.  There is no cost to participate, other than a vet fee for drawing a blood sample (many vets are doing this at cost or minimal charge, to support the research) and overnight shipping charges to the lab ($12-$30 from most places in the country via FedEx, UPS, or US Mail).  If you have any questions, or need additional information, please contact project coordinator Liz Hansen via one of the methods listed below. Thank you for your interest and participation!

Liz Hansen
Coordinator of Veterinary Information
hansenl@missouri.edu (office email)

The forms may also be obtained by contacting Ruth Peacock by mail at 6095 James Bell Drive, Manotick, ON, K4M 1B3 and copies will be mailed to you.

Note:  To pass customs from other countries, the package needs to be labeled "DNA samples - No Infectious Agents" and it will go through.

NOTE:  Due to the fact that Dr. Johnson's all-breed study is operating in conjunction with the Canadian Epilepsy study (OVC, U of T, Guelph University and Toronto Sick Kids) which is more Toller specific at this time , it has been requested that all Toller samples and information be sent to the following address:

Jennifer Rilstone/Minassian Lab
The Hospital for Sick Children
MaRS Centre
Toronto Medical Discovery Tower
101 College St, 15-311
Toronto ON
M5G 1L7
Blood collection and shipping information can be obtained from Ruth Peacock.

********************************************************************************************************************

More Epilepsy information can be found at the following link:

http://www.canine-epilepsy.com/Resources.html

http://www.canine-epilepsy-guardian-angels.com/

http://www.k9web.com/dog-faqs/medical/epilepsy.html


Addison's Disease Study

Angela M. Hughes DVM, Veterinary Genetics Resident, Veterinary Medical Teaching Hospital
School of Veterinary Medicine. University of California, Davis, is undertaking a study on Addison's disease in the Toller.  This is Dr. Hughes' resident research project and she will be conducting it under the guidance of Drs. Bannasch (Genetics), Oberbauer (Genetics), Famula (Statistics), and Nelson (Internal Medicine)."  Here is the general information letter from Dr. Hughes.  Following the letter you will find the Sample ID Form and the Blood Sample Collection and Shipping Proceedures, both in .pdf format.

Addison’s Disease Study in Nova Scotia Duck Tolling Retrievers

Thank you for your interest and support of the Nova Scotia Duck Tolling Retriever Addison’s disease study.  We are currently collecting information and DNA samples (blood or cheek swabs) on affected and unaffected Tollers.  The information we are collecting on these Tollers includes: registered name, dam and sire, date of birth, spay/neuter status, Addison’s disease status (if no, any relatives that are affected), age at disease onset, any other disease history (especially immune related diseases), and coat markings (positions of white, eye rim/nose color).  I realize that we are asking for a lot of information on this sheet, but we would greatly appreciate it if you could please read the form carefully and fill it out completely for each Toller that you are submitting a DNA sample.  It is critical that we have complete entries for each dog in our database.  Please include a copy of the pedigree if you have one available.  ***Additionally, for Tollers that have been diagnosed with Addison’s disease, we would like a copy of any ACTH stimulation tests that have been performed by your veterinarian.  This helps us confirm the diagnosis of Addison’s disease.***

A blood sample can be collected by your veterinarian according to the instructions in the “Blood Sample Collection” information sheet attached to this email.  The address to send samples to is also included on this sheet.  If you prefer to use cheek swabs to send in your dog’s DNA sample, please contact Dr. Hughes for swabs and instructions.

The information you provide for the study and your dog’s genetic results will be kept strictly confidential.  However, if you would like your affected dog’s name included on a public list of Tollers with Addison’s disease, please mark the appropriate box on the information sheet.  Additionally, if you would like to authorize use of your dog’s DNA in future research projects, please mark the appropriate box.

Results of this study pertaining to the breed as a whole, e.g. mode of inheritance, any markers or genes located, etc., will be shared with the Toller clubs.  However, any information determined for individual animals will be considered the property of the researchers only and will not be disclosed.  If and when an accurate and reliable genetic test for Addison’s disease in Tollers is available, we will be able to address the issue of an individual’s genetic predisposition to develop Addison’s disease.

Thank you again for your assistance with this study.  If you have any further questions, please direct them to Dr. Hughes at (530)754-2117 or ahughes@ucdavis.edu.

Download the following forms by clicking on their name:

Sample ID Form
Blood Sample Collection & Shipping Proceedures

********************************************************************************************************************

Further information on Addisons Disease can be found at the following links.  Addisons Disease is seen in Tollers at an age not common to other breeds and some veterinarians may not consider it when diagnosing a problem. Some Tollers have been diagnosed with it as young as 4 months of age.

http://beaconforhealth.org/Addisons.htm

http://www.geocities.com/Heartland/Hills/4263/addisons.html